
Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients
CNN
Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
More Related News

Before South African high school students complete their final exams, they first walk the red carpet, pulling out all the stops for their celebratory matriculation, or ‘matric,’ balls. The photographer Alice Mann documented the increasingly lavish dances for five years in her new book, “The Night is Young.”












